Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
2.030
+0.020 (1.00%)
Jan 17, 2025, 4:00 PM EST - Market closed
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $3.02 million as of January 17, 2025. Its market cap has increased by 123.27% in one year.
Market Cap
3.02M
Enterprise Value
-1.76M
1-Year Change
123.27%
Ranking
Category
Stock Price
$2.03
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $3.02M, a decrease of -92.67%. That is a compound annual growth rate of -57.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 3.02M | - |
| Dec 31, 2024 | 3.02M | 134.67% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |